EditorJ

Mammoth Biosciences announces new results on NanoCas – the first efficient ultracompact extrahepatic gene editor

Samsung Biologics expands US manufacturing capacity with acquisition from GSK

Two-part white paper introduces pharma R&D through AI

New deal to expand immune portfolio

Powerful new antibiotic class to tackle new deadly superbugs discovered

Pioneering iPSC research and in vivo data for treatment of Parkinson’s Disease

Henlius and Organon achieve first US Perjeta biosimilar approval

Gene Solutions secures patent for mitochondrial therapy platform targeting neurological diseases

Andembry recommended for routine use in the prevention of hereditary angioedema attacks

Craig Rhodes appointed head of partnerships